Skip to main content
. 2021 Nov 2;7(3):e001694. doi: 10.1136/rmdopen-2021-001694

Figure 3.

Figure 3

Kaplan-Meier survival curves for patients <50 years (A) and ≥50 years of age B) with (1) rheumatoid arthritis (RA, N=7099 <50 years, N=35 636 ≥50years), (2) ankylosing spondylitis (AS, N=5466 <50 years, N=4241 ≥50years), (3) psoriatic arthritis (PSA, N=5048 <50 years, N=8731 ≥50years), (4) systemic lupus erythematosus (SLE, N=4373 <50 years, N=6067 ≥50years), (5) systemic sclerosis (SSC, N=600 <50 years, N=1677 ≥50 years) and for age-matched and gender-matched individuals from the general population (1:5 exposed:unexposed ratio) included in our cohort between 1 January 2015 and 31 December 2019. Analysis time in months.